Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine.

Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine. Vaccine. 2009 Sep 18; 27(41):5612-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.